Podcasts

Dr. Matthew Hiemenz and Dr. Damon Olson discuss molecular testing practices for sarcomas to help differentiate between types.

This month we'll review the proposed 2023 Medicare Payment Regulations released by the CMS, the technical reporting changes made to CLIA proficiency testing regulations, as well as the declaration of Mpox as a global health emergency and a public health emergency in the United States. We will also be joined by Theresa Emory, MD, FCAP, to talk about good faith estimate requirements as they relate to surprise medical bills.

This month we'll look at updates on the VALID Act, examine the CDC announcement for Mpox specimen guidelines, and review the decision by the CMS to retain diagnostic codes for next-generation sequencing.

This month we'll be focusing on the VALID Act and its impact on laboratory-developed tests. We sat down with CAP President Dr. Emily Volk to get some background on the legislation and what to expect moving forward.

Pathologists are responsible for developing safe and efficient blood selection policies for routine and emergency bleeding situations, in a variety of clinical scenarios and in different practice settings, explains Monica Pagano, MD, FCAP, in this CAPcast interview.

This month we recognize National Minority Health Month, look at the request for additional COVID funding, learn about new efforts in pandemic preparedness, and review highlights from this year's pathologists leadership summit with Vaishali Pansare, MD, FCAP.

CAP Cancer Protocols play an important role in disease management, ensuring that all pathology reports contain necessary data elements to improve patient care. The CAP has nine protocols for head and neck-related cancers, as Raja Seethala, MD, FCAP, explains in this CAPcast episode.

Assessing whether to insource or outsource a practice’s billing operations is the focus of this CAPcast episode, which features a recording of a Practice Management Committee Roundtable Discussion moderated by Committee Chair Karim Sirgi, MBA, MD, FCAP.

This month we'll look at recent efforts to strengthen the national blood supply, the passing of an omnibus bill by Congress, and the latest updates about the PREVENT Pandemics Act.

Early detection through prevention and screening is proven to dramatically reduce fatalities from this cancer. The CAP Cancer Protocols help ensure that all pathology reports contain the necessary data elements to improve patient care.

New in Practice Committee members Drs. Alan Brown and Jaclyn Rudzinski discuss common financial challenges and issues for fellows and new attendings, including common pathology practice structures as well as the importance of balancing debts and savings.

In this CAPcast, John Sinard, MD, FCAP, discusses the educational case he has developed to teach planning tools related to successfully implementing histology tracking software.

This month we’ll look at the Biden administration's relaunch of its cancer moonshot initiative, addressing social determinants of health, and more.

In this CAPcast, Moira Larsen, MD, MBA, FCAP, and Karim Sirgi, MD, MBA, FCAP, will discuss how to determine workload distribution while navigating the associated group dynamics.

Trichomoniasis is the most common, non-viral, sexually transmitted infection. Pathologists providing laboratory testing for this infection should understand the advantages and disadvantages of the commercially available, FDA-approved/cleared methods.

A new study just published in the Archives of Pathology & Laboratory Medicine found that pathology abnormalities composing SARS-CoV-2 placentitis cause widespread and severe placental destruction that can result in stillbirths.

This month we'll look at testing supply shortages caused by the Omicron variant, new dispute guidelines in the No Surprises Act, and more.

In this CAPcast, Dr. Rebecca Obeng discusses the range of services and resources that biorepositories can provide researchers as well as the benefits and value of accreditation for biorepositories.

In this CAPcast, Matthew Krasowski, MD, FCAP, Chair of the CAP Toxicology Committee, discusses the laboratory’s role in medical device recall, such as this recent incident, and how both CAP-accredited laboratories and inspectors should respond to recalls.

The CAP is advocating to make the IDR process truly independent and fair to all participants. We spoke with Dr. Theresa Emory, chair of the CAP's Payment Policy Subcommittee, to learn more.